NEW YORK, Dec. 12 — Deltagen announced Wednesday that it had appointed Majid Mehtali as scientific director of Deltagen Europe, the company’s new genomics research and development center in Strasbourg, France.

Mehtali will lead Deltagen Europe’s efforts to expand its in vivo research work. The company’s principal product is a database of in vivo derived mammalian gene function information, used by pharmaceutical companies to discover and validate drug targets.  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.